Product Name | MF | CAS | Details |
---|
5-NITRO-1,3,6-TRIMETHYLURACIL | C7H9N3O4 | 55326-07-3 | Details |
N-ACETYL-DL-ETHIONINE | C8H15NO3S | 57271-88-2 | Details |
RCL T205699 | C18H22O3 | 79997-57-2 | Details |
TGF-β1, Human, Recombinant, CHO Cell Line | Details |
5,5-PENTAMETHYLENE-3-VINYLHYDANTOIN | C10H14N2O2 | 86710-07-8 | Details |
2-Methyl-6-(tributylstannyl)pyridine | C18H33NSn | 259807-95-9 | Details |
3-(Triethoxysilyl)furan | C10H18O4Si | 75905-12-3 | Details |
Anti-IKAROS Antibody | Details |
3,17-DIOXOANDROST-4-EN-6-BETA-YL ACETATE | Details |
Cyclin E1 Protein complex, 250 μg | Details |
9-BR-2-(2-FURYL)-5-(4-METHOXY-PH)-1,10B-DIHYDROPYRAZOLO(1,5-C)(1,3)BENZOXAZINE | C21H17BrN2O3 | 883813-61-4 | Details |
ETHYL 7-(1-NAPHTHOYL)-3-(2-NAPHTHYL)PYRROLO(1,2-C)PYRIMIDINE-5-CARBOXYLATE | C31H22N2O3 | 883824-49-5 | Details |
Volasertib | C34H50N8O3 | 755038-65-4 | Details |
Ethyl 3-(4-chlorophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylate | C13H9ClF3NO3 | Details |
Monoclonal Anti-MPP5 antibody produced in mouse | Details |
Bcl-xL Blocking Peptide for SAB3500349 | Details |
ET 7-(4-FLUOROBENZOYL)-3-(4-METHOXYPHENYL)PYRROLO(1,2-C)PYRIMIDINE-5-CARBOXYLATE | C24H19FN2O4 | 302912-86-3 | Details |
n-piperidin-4-yl-methanesulfonamide | C6H14N2O2S | Details |
4-(4-HO-BENZYLIDENE-HYDRAZINOCARBONYL)-1-(2-OXO-2-PH-ETHYL)-PYRIDINIUM, BROMIDE | 467446-75-9 | Details |
N-(2-{(2E)-2-[2-(ALLYLOXY)-5-BROMOBENZYLIDENE]HYDRAZINO}-2-OXOETHYL)-4-METHOXYBENZAMIDE | C20H20BrN3O4 | 881471-02-9 | Details |
Corning? coliform water test sample container, sterile | Details |
3-HYDROXY-3-PIPERIDINO-4,5,6,7-TETRACHLOROPHTHALIDE | C13H11Cl4NO3 | 80992-15-0 | Details |
PTFE syringe tubing | Details |
N-(5-NITRO-2-PYRIDYL)OCTYLAMINE | C13H21N3O2 | 200617-86-3 | Details |
4-(1-Piperidinylsulfonyl)benzoic acid | C12H15NO4S | Details |
1-(3,4-dihydroxyphenyl)-2-(isopropylamino)-2-methyl-1-propanone hydrobromide | Details |
4-(2-(2-IODOBENZOYL)CARBOHYDRAZONOYL)PHENYL 2-METHYLBENZOATE | C22H17IN2O3 | 880030-74-0 | Details |
Human GFR alpha-2 ELISA | Details |
ETHYL 2-CYANO-3-((2-METHYL-1,3-BENZOTHIAZOL-6-YL)AMINO)ACRYLATE | 892148-53-7 | Details |
Omegawax Capillary GC Column | Details |
2-(2,4-DICHLOROPHENOXY)ETHYL LACTATE | C11H12Cl2O4 | 110534-41-3 | Details |
1-HYDROXY-2-TRIDECANAMINIUM CHLORIDE | C13H30ClNO | 24459-77-6 | Details |
ATR/CDK Inhibitor, NU6027 | C11H17N5O2 | 220036-08-8 | Details |
1-(4-METHYLBENZYL)-5-OXOPROLINE | C13H15NO3 | 87341-45-5 | Details |
Mersalyl acid | C13H17HgNO6 | 486-67-9 | Details |
2-(4-BR-PHENOXY)-N'-((2-OXO-1,2-DIHYDRO-3-QUINOLINYL)METHYLENE)PROPANOHYDRAZIDE | C19H16BrN3O3 | 880042-60-4 | Details |
N-(3-CHLORO-2-METHYLPHENYL)-2-(2-(1-NAPHTHYLMETHYLENE)HYDRAZINO)-2-OXOACETAMIDE | C20H16ClN3O2 | 341956-02-3 | Details |
Anti-FAM240C antibody produced in rabbit | Details |
N'-(5-BROMO-2-FLUOROBENZYLIDENE)-3-PHENYL-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C17H12BrFN4O | 868285-58-9 | Details |
A10? TOC Monitor | Details |
Anti-FBXL22 antibody produced in rabbit | Details |
Rabbit anti-TCP1 Antibody, Affinity Purified | Details |
Cell Dissociation Solution Non-enzymatic 1x | Details |
2-Bromo-2′,6′-dichloro-3′-fluoroacetophenone | C8H4BrCl2FO | Details |
1-PHENYL-4-(PHENYLSULFONYL)PIPERAZINE | C16H18N2O2S | 74130-02-2 | Details |
SB-BCRP-HEK293 | Details |
METHYL (2E)-2-(4-TERT-BUTYLBENZYLIDENE)-7-METHYL-3-OXO-5-(2-THIENYL)-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE | C24H24N2O3S2 | 518985-10-9 | Details |
LUPAN-3-BETA-YL IODOACETATE | Details |
Transformer, 230V (Great Britian) | Details |
METHYL 2-METHYL-6-NITROPHENYL CARBONATE | C9H9NO5 | 883788-94-1 | Details |
N'-(3-BROMOBENZYLIDENE)-3-(5-BROMO-2-THIENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C15H10Br2N4OS | 402502-85-6 | Details |
SLAP 2,3-Bicyclo-(3,4-THF) N-BnPip Reagent | Details |
Anti-MKI67 antibody produced in rabbit | Details |
Anti-TAP1 antibody produced in goat | Details |
2-[9-BROMO-2-(2-NAPHTHYL)-1,10B-DIHYDROPYRAZOLO[1,5-C][1,3]BENZOXAZIN-5-YL]PHENYL METHYL ETHER | C27H21BrN2O2 | 303095-31-0 | Details |
Tiagabine Related Compound A | C22H30ClNO2S2 | 145821-60-9 | Details |
4-(((3-MERCAPTO-5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOL-4-YL)IMINO)METHYL)PHENOL | C16H14N4OS | 478256-01-8 | Details |
Fmoc- |
C20H21NO4 | 84624-17-9 | Details |
3-METHOXY-2-METHYL-6-(4-(4-PROPYL-PHENOXY)-1H-PYRAZOL-3-YL)-PHENOL | 385401-25-2 | Details |
BENZALDEHYDE N-(3-CHLOROPHENYL)THIOSEMICARBAZONE | C14H12ClN3S | 107774-86-7 | Details |
2-AMINO-4-(5-TERT-BUTYL-2-THIENYL)-1-(3-CYANO-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIEN-2-YL)-7,7-DIMETHYL-5-OXO-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBONITRILE | C30H34N4OS2 | 312315-96-1 | Details |
Monoclonal Anti-CD98-Biotin antibody produced in mouse | Details |
PEEK Tubing | Details |
2-(Cyclopentyloxy)nicotinaldehyde | C11H13NO2 | Details |
Mefloquine Related Compound A | C17H17ClF6N2O | 51744-85-5 | Details |
1-[1,2-DIBROMO-2-(3,5-DIMETHYLPHENYL)ETHYL]-3,5-DIMETHYLBENZENE | 883835-38-9 | Details |
Anti-ADGRE5 antibody produced in rabbit | Details |
CARBOBENZYLOXY-L-LEUCINE DICYCLOHEXYLAMINE SALT | Details |
Anti-BXDC2 antibody produced in mouse | Details |
Anti-FGF11 antibody produced in rabbit | Details |
DIMETHYL 2-((4-CHLORO-3-NITROBENZOYL)AMINO)TEREPHTHALATE | C17H13ClN2O7 | 328258-36-2 | Details |
4-CHLOROPHENYL METHYL SULFIDE | C7H7ClS | 123-09-1 | Details |
4-((4-BENZYL-PIPERAZIN-1-YLIMINO)-METHYL)-BENZOIC ACID METHYL ESTER | C20H23N3O2 | 307328-28-5 | Details |
4-Methoxybenzaldehyde | C8H8O2 | 123-11-5 | Details |
Methyl 2-nitrobenzoate | C8H7NO4 | 606-27-9 | Details |
4(2-(BIS(4-CL-PHENOXY)AC)CARBOHYDRAZONOYL)PH 3-CL-1-BENZOTHIOPHENE-2-CARBOXYLATE | C30H19Cl3N2O5S | 880029-39-0 | Details |
Anti-Glial Fibrillary Acidic Protein (GFAP) Mouse mAb (G-A-5) | Details |
N'-[(E)-(5-BROMO-2-FLUOROPHENYL)METHYLIDENE]-2-{[1-(4-METHYLBENZYL)-1H-BENZIMIDAZOL-2-YL]SULFANYL}ACETOHYDRAZIDE | C24H20BrFN4OS | 402511-06-2 | Details |
K40-I GEN3 V2 CRITICAL SPARES | Details |
RCL T250872 | C30H54O3Si2 | 1217498-77-5 | Details |
4-Amino-15N-2-chloro-6-isopropylamino-1,3,5-triazine | Details |
(R)-()-2-(tert-Butyl)-3-methyl-4-imidazolidinone trifluoroacetic acid | C10H17F3N2O3 | 900503-36-8 | Details |
3-[(4-CHLOROPHENYL)SULFONYL]-1-(2-NAPHTHYL)-1-PROPANONE | C19H15ClO3S | 868256-12-6 | Details |
N'-BENZYLIDENE-2-(4-BROMOPHENOXY)ACETOHYDRAZIDE | C15H13BrN2O2 | 303063-90-3 | Details |
α-Bromoisobutyryl bromide | C4H6Br2O | 20769-85-1 | Details |
3-Hydroxytyramine hydrobromide | C8H12BrNO2 | 645-31-8 | Details |
Domperidone | C22H24ClN5O2 | 57808-66-9 | Details |
PDGFR Tyrosine Kinase Inhibitor II | C21H18N2O3 | 249762-74-1 | Details |
4,6-DIMETHYL-2-(PHENYLTHIO)PYRIMIDINE | C12H12N2S | 92902-64-2 | Details |
3,10-DIMETHYLTRICYCLO[4.2.2.0(2,5)]DECA-3,9-DIENE-7,7,8,8-TETRACARBONITRILE | C16H12N4 | 42114-44-3 | Details |
3-METHYL-7-OCTYL-8-[(2Z)-2-(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)HYDRAZINO]-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | 328117-68-6 | Details |
6-CHLORO-3-(2-(4-FLUORO-PHENYL)-2-OXO-ETHYL)-3H-QUINAZOLIN-4-ONE | 202808-33-1 | Details |
Anti-NKR-P1G (KLRB1) Antibody, clone 8A10 | Details |
Anti-Para 2, clone 233/9A (1mL)KC | Details |
N'-[(E)-(2,3-DIMETHOXYPHENYL)METHYLIDENE]-3-(2-METHOXY-1-NAPHTHYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | 307322-38-9 | Details |
N'-[(4-METHYLPHENYL)METHYLIDENE]-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE-2-CARBOHYDRAZIDE | 1119448-76-8 | Details |
Heat-Labile Enterotoxin, B subunit (LTB) from E. coli | Details |
Anti-GPR31 antibody produced in rabbit | Details |
Raptor (AB1) Blocking Peptide for PRS3489 | Details |
N-(3,4-DICHLOROPHENYL)-N'-(5-HYDROXY-1-NAPHTHYL)UREA | C17H12Cl2N2O2 | 303092-11-7 | Details |
Product Total: Product Page: | ||||
781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 |